Login to Your Account


'In it for the long run': Tokalas merger building Oncternal's pipeline

By Jennifer Boggs
Managing Editor

Monday, October 10, 2016

Earlier this year, the quiet joining of two recent San Diego-based startups led to the creation of Oncternal Therapeutics Inc., an oncology-focused firm boasting two potentially first-in-class drugs, both of which already have entered the clinic.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription